Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.

ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest (2010) 1.45

Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal (2009) 1.14

Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis. PLoS One (2010) 1.11

Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg (2008) 1.04

Insulin treatment enhances the myocardial angiogenic response in diabetes. J Thorac Cardiovasc Surg (2007) 0.91

Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia. Surgery (2011) 0.84

Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles. Expert Rev Cardiovasc Ther (2011) 0.83

Pathophysiology of myocardial injury and remodeling: implications for molecular imaging. J Nucl Med (2010) 0.76

Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure. Neth Heart J (2007) 0.76

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11

Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation (2008) 5.97

Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59

Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardiothorac Surg (2013) 3.22

An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg (2006) 3.09

Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation (2008) 3.06

Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation (2006) 2.72

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation (2008) 2.63

Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A (2002) 2.60

Skeletonized internal thoracic artery harvest reduces pain and dysesthesia and improves sternal perfusion after coronary artery bypass surgery: a randomized, double-blind, within-patient comparison. Circulation (2006) 2.54

Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation (2010) 2.51

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation (2002) 2.39

The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg (2009) 2.32

Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. Eur J Cardiothorac Surg (2005) 2.19

Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg (2004) 2.13

Radial artery graft treatment with phenoxybenzamine is clinically safe and may reduce perioperative myocardial injury. Ann Thorac Surg (2007) 2.10

Effects of alcohol on pericardial adhesion formation in hypercholesterolemic swine. J Thorac Cardiovasc Surg (2012) 2.07

A 69-year-old woman with left main coronary artery disease. JAMA (2004) 2.04

Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg (2006) 2.02

Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases. Circulation (2012) 1.93

Patient safety in the cardiac operating room: human factors and teamwork: a scientific statement from the American Heart Association. Circulation (2013) 1.86

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79

Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle (2009) 1.77

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J Med Chem (2007) 1.73

Changing malaria transmission and implications in China towards National Malaria Elimination Programme between 2010 and 2012. PLoS One (2013) 1.72

Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and meta-analysis. Heart (2011) 1.70

The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg (2008) 1.68

Reoperation of left heart valve bioprostheses according to age at implantation. Circulation (2011) 1.68

High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine. J Thorac Cardiovasc Surg (2006) 1.66

Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg (2006) 1.64

The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg (2007) 1.64

Minimally invasive coronary artery bypass grafting: dual-center experience in 450 consecutive patients. Circulation (2009) 1.62

Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery. Ann Thorac Surg (2005) 1.61

Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol (2005) 1.60

Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res (2005) 1.60

Enlargement of the small aortic root during aortic valve replacement: is there a benefit? Ann Thorac Surg (2008) 1.60

Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation (2006) 1.58

Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation (2005) 1.57

Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg (2011) 1.56

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. J Thorac Cardiovasc Surg (2010) 1.56

PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation. J Chem Inf Model (2005) 1.54

Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration. Catheter Cardiovasc Interv (2003) 1.49

Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells. Ann Thorac Surg (2008) 1.47

Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47

Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation (2007) 1.47

2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (2014) 1.44

Percutaneous retrieval of fractured Bird's Nest IVC filter penetrating into aorta. Catheter Cardiovasc Interv (2012) 1.42

Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol (2008) 1.41

Effect of sodium tanshinone II A sulfonate on phosphorylation of extracellular signal-regulated kinase 1/2 in angiotensin II-induced hypertrophy of myocardial cells. Chin J Integr Med (2008) 1.40

Intraoperative indocyanine green angiography: ready for prime time? J Thorac Cardiovasc Surg (2007) 1.39

Comparison of the EuroSCORE and Cardiac Anesthesia Risk Evaluation (CARE) score for risk-adjusted mortality analysis in cardiac surgery. Eur J Cardiothorac Surg (2011) 1.39

Aortic valve cusp shearing and migration into the left main coronary artery during transcatheter aortic valve implantation. Can J Cardiol (2012) 1.39

High flow rates during modified ultrafiltration decrease cerebral blood flow velocity and venous oxygen saturation in infants. Ann Thorac Surg (2005) 1.39

The peer-review process in medical publishing: a reviewer's perspective. J Thorac Cardiovasc Surg (2003) 1.39

Positive correlation between neovascularization degree of carotid atherosclerosis determined by contrast-enhanced ultrasound and level of serum C-reactive protein. Vasa (2015) 1.38

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation (2010) 1.37

Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegic arrest. Circulation (2008) 1.36

MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep (2010) 1.34

A new and simplified method for coronary and graft imaging during CABG. Heart Surg Forum (2002) 1.31

Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med (2013) 1.28

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 1.28

Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.27

Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide. J Med Chem (2002) 1.27

Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia. Basic Res Cardiol (2012) 1.26

Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci (2008) 1.26

Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26

Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol (2011) 1.25

Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg (2003) 1.23